Amgen (NASDAQ:AMGN) today announced new interim results from the global Phase 3 DeLLphi-304 trial showing IMDELLTRA® (tarlatamab-dlle) reduced the risk of death by 40% and significantly extended ...

The world's tallest 3D-printed building, measuring almost 100 feet (30 metres) in height, has been unveiled in the small ...